RSS

Catalent

Do you encounter difficulties when swallowing tablets? Head of product development at Catalent Pharma Solutions, Ralph Gosden, reveals why the Zydis platform is still a game changer, and what is on the cards for the near future. more

Opinion

Global provider of advanced delivery technologies and development solutions, Catalent, and clinical-stage biotechnology company, Vaccinex, have signed an agreement for the development of an antibody drug conjugate (ADC) to be used against cancer more

News

As we reach the end of CPhI Worldwide, we have some more revelations and innovations that keep coming from the vast show floor here in Frankfurt Messe, enjoy and until next year tschüß! more

News

Here, Michael Merges, Catalent Biologics, and Brian Fahie, Biogen, discuss the growing need for partners who can provide niche technologies to accelerate development projects. more

, Opinion

Global provider of advanced delivery technologies and development solutions for drugs, Catalent, has reached an agreement to purchase Cook Pharmica, an integrated provider of drug substance and drug product manufacturing and related services. more

News

As Catalent further expands its softgel drug delivery capabilities with its acquisition of Accucaps, we speak with June Lin, global marketing director consumer health softgel, about the benefits these expanded capabilities will offer. more

Opinion

Catalent Pharma Solutions has revealed its agenda for the upcoming CPhI North America Conference and Exhibition more

News

Global supply partner for drugs, biologics and consumer health products, Catalent, has announced that it has completed the acquisition of pharmaceutical softgels developer and manufacturer, Accucaps. more

News

Chris Halling, director, global communications & marketing at Catalent writes about how drug design affects patient adherence. more

News

Provider of advanced delivery technologies and development solutions for drugs, Catalent Pharma Solutions has announced it will develop softgel technology for pharma company, Jupiter Orphan Therapeutics’ (JOT) formulation of resveratrol, JOTORL. more

News

Catalent Pharma Solutions, provider of advanced delivery technologies and development solutions for drugs has announced a collaboration with Path, a nonprofit organisation to advance a project funded by its Malaria Vaccine Initiative. more

News

Global CDMO Catalent has announced its enrollment in the Pharmaceutical Supply Chain Initiative (PSCI) more

News

Provider of advanced delivery technologies, Catalent Pharma Solutions, has announced it will provide fill-finish production services for the commercial supply of SB4, a biosimilar referencing Enbrel, which is used to treat five chronic diseases. more

News

Acquisition of west coast development and clinical manufacturing specialist will add formulation development capabilities and expands bioavailability enhancement solutions. more

News

Catalent Pharma Solutions has announced a commercial supply agreement with Palatin Technologies to globally launch Palatin’s bremelanotide pen injector product, which is used to treat female sexual dysfunction (FSD) more

News

Jennifer Mitcham, Catalent Biologics, offers insight into the new generation of antibody drug conjugates and the increasing importance biologics play in the fight against disease more

Opinion

Workshop will discuss accelerated preclinical drug development and readying molecules for phase I more

News

What’s hot for 2016? Lu Rahman asks key industry players what they think the key pharma trends will be for the coming year more

Opinion

Catalent’s softgel plant in Beinheim, France received notification from l’Agence National de Sécurité du Médicament et des produits de santé (ANSM) requiring the suspension of manufacturing within the site more

News

Catalent Pharma Solutions has announced the multi-site expansion of its analytical and process development capabilities for biologics more

News